R Kulkarni

Summary

Affiliation: Michigan State University
Country: USA

Publications

  1. ncbi Comprehensive care of the patient with haemophilia and inhibitors undergoing surgery: practical aspects
    R Kulkarni
    Division of Pediatric and Adolescent Hematology Oncology, Department of Pediatrics and Human Development, Michigan State University College of Human Medicine, East Lansing, MI 48824, USA
    Haemophilia 19:2-10. 2013
  2. ncbi Pediatric hemophilia: a review
    Roshni Kulkarni
    Department of Pediatrics and Human Development, Michigan State University, East Lansing, Michigan 48824, USA
    Semin Thromb Hemost 37:737-44. 2011
  3. ncbi Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project
    R Kulkarni
    Division of Blood Disorders, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Haemophilia 15:1281-90. 2009
  4. ncbi Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres
    V R Byams
    Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Haemophilia 17:6-13. 2011
  5. ncbi Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA
    R Kulkarni
    Department of Pediatrics and Human Development, Michigan State University, East Lansing, MI 48824, USA
    Haemophilia 12:205-11. 2006
  6. ncbi Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophili
    R Kulkarni
    Michigan State University, Paediatrics Human Development, B401 Clinical Center, 138 Service Road, East Lansing, MI 48824 1313, USA
    Haemophilia 5:410-5. 1999
  7. ncbi Nondisclosure of human immunodeficiency virus and hepatitis C virus coinfection in a patient with hemophilia: medical and ethical considerations
    R Kulkarni
    Department of Pediatrics Human Development, Michigan State University, East Lansing, USA
    J Pediatr Hematol Oncol 23:153-8. 2001
  8. ncbi The spectrum of haemostatic characteristics of women with unexplained menorrhagia
    C H Miller
    Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Haemophilia 17:e223-9. 2011
  9. ncbi The longitudinal effect of body adiposity on joint mobility in young males with Haemophilia A
    J M Soucie
    National Center on Birth Defects and Developmental Disabilities, Division of Blood Disorders, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Haemophilia 17:196-203. 2011
  10. ncbi Therapeutic choices for patients with hemophilia and high-titer inhibitors
    R Kulkarni
    Pediatrics Human Development, Michigan State University, East Lansing, Michigan 48824 1313, USA
    Am J Hematol 67:240-6. 2001

Collaborators

Detail Information

Publications15

  1. ncbi Comprehensive care of the patient with haemophilia and inhibitors undergoing surgery: practical aspects
    R Kulkarni
    Division of Pediatric and Adolescent Hematology Oncology, Department of Pediatrics and Human Development, Michigan State University College of Human Medicine, East Lansing, MI 48824, USA
    Haemophilia 19:2-10. 2013
    ....
  2. ncbi Pediatric hemophilia: a review
    Roshni Kulkarni
    Department of Pediatrics and Human Development, Michigan State University, East Lansing, Michigan 48824, USA
    Semin Thromb Hemost 37:737-44. 2011
    ..Currently, inhibitors and ICH are the most challenging complications and prophylaxis is emerging as the optimal preventive care strategy...
  3. ncbi Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project
    R Kulkarni
    Division of Blood Disorders, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Haemophilia 15:1281-90. 2009
    ..This study highlights the significant rate and the sites of initial bleeding unique to very young children with haemophilia and underscores the need for research to identify optimal evidence-based recommendations for their management...
  4. ncbi Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres
    V R Byams
    Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Haemophilia 17:6-13. 2011
    ..The female UDC is the first prospective, longitudinal surveillance in the US focusing on FBD and has the potential to further identify complications and reduce adverse outcomes in this population...
  5. ncbi Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA
    R Kulkarni
    Department of Pediatrics and Human Development, Michigan State University, East Lansing, MI 48824, USA
    Haemophilia 12:205-11. 2006
    ..This document outlines the needs for further research and education, summarizes the state of the art background information and provides guidance regarding research, education and access to care issues in this population...
  6. ncbi Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophili
    R Kulkarni
    Michigan State University, Paediatrics Human Development, B401 Clinical Center, 138 Service Road, East Lansing, MI 48824 1313, USA
    Haemophilia 5:410-5. 1999
    ..Physicians need to be made aware that ICH may be a presenting sign of haemophilia in both term as well as pre-term newborns, so that appropriate therapy can be instituted early in the event of a bleed...
  7. ncbi Nondisclosure of human immunodeficiency virus and hepatitis C virus coinfection in a patient with hemophilia: medical and ethical considerations
    R Kulkarni
    Department of Pediatrics Human Development, Michigan State University, East Lansing, USA
    J Pediatr Hematol Oncol 23:153-8. 2001
    ..he is at potential risk for transmitting HIV/HCV outweigh the rights of the family? What are the rights of the rest of the family? What are the rights of the minor? Is it our ethical responsibility to disclose a probably fatal diagnosis?..
  8. ncbi The spectrum of haemostatic characteristics of women with unexplained menorrhagia
    C H Miller
    Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Haemophilia 17:e223-9. 2011
    ..S. sites. To what degree these abnormalities are clinically significant requires further study...
  9. ncbi The longitudinal effect of body adiposity on joint mobility in young males with Haemophilia A
    J M Soucie
    National Center on Birth Defects and Developmental Disabilities, Division of Blood Disorders, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Haemophilia 17:196-203. 2011
    ..Our findings suggest that body weight control and effective treatment of bleeds should be implemented together to achieve better joint ROM outcomes in males with haemophilia...
  10. ncbi Therapeutic choices for patients with hemophilia and high-titer inhibitors
    R Kulkarni
    Pediatrics Human Development, Michigan State University, East Lansing, Michigan 48824 1313, USA
    Am J Hematol 67:240-6. 2001
    ..The workshop participants felt that future research offers the best solution to resolve some of the dilemmas faced by clinicians and may help individualise treatment in a hemophilia patient with a high titer inhibitor...
  11. ncbi Venous thromboembolism
    R Gera
    Michigan State University, Clinical Centre, East Lansing 48824 1313, USA
    Indian J Pediatr 66:163-9. 1999
    ..Thrombolytic therapy may be indicated in some cases. Clinical presentation, management and pathogenesis including role of congenital prethrombotic disorders in pediatric VTE are discussed...
  12. ncbi The U.S. Thrombosis and Hemostasis Centers pilot sites program
    N F Dowling
    Division of Hereditary Blood Disorders, National Center on Birth Defects and Developmental Disorders, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Thromb Thrombolysis 23:1-7. 2007
    ..The network of data collection across centers will facilitate future collaborative clinical and epidemiologic investigations and enhance collective expertise in hemostasis and coagulation disorders...
  13. ncbi Renal disease among males with haemophilia
    R Kulkarni
    Department of Pediatrics/Human Development, Michigan State University, East Lansing, MI, USA
    Haemophilia 9:703-10. 2003
    ..In summary, we found that HIV infection and haemophilia-related factors including inhibitors and kidney bleeds were associated with renal disease in a cohort of males with haemophilia...
  14. ncbi Pediatric transfusion therapy: practical considerations
    R Kulkarni
    Michigan State University, East Lansing 48824 1313, USA
    Indian J Pediatr 66:307-17. 1999
    ....
  15. ncbi Successful treatment of high titer inhibitors in mild hemophilia A with avoidance of factor VIII and immunosuppressive therapy
    D Robbins
    Michigan State University, Department of Pediatrics/Human Development, B220 Clinical Center, 138 Service Road, East Lansing, Michigan 48824-1313, USA
    Am J Hematol 68:184-8. 2001
    ..Recombinant factor VIIa (rFVIIa) was used successfully prior to a second surgery in one patient without complication...